Lexiva May be Associated With Higher Risk of Heat Attacks, High Cholesterol, FDA Warns (NewsInferno)

December 4, 2009

Lexiva, an HIV medication marketed by GlaxoSmithKline, has been associated with a potential increase in heart attacks in adult HIV patients, and has been seen to raise cholesterol levels, according to the Food & Drug Administration (FDA).

See the original post here:
Lexiva May be Associated With Higher Risk of Heat Attacks, High Cholesterol, FDA Warns (NewsInferno)

Contact a Zicam Attorney!